Drug-induced DNA hypermethylation: A potential mediator of acquired drug resistance during cancer chemotherapy

Mutation Research - Reviews in Mutation Research

Volumn 386, Issue 2, 1997, Pages 153-161

  Nyce, Jonathan W ^a  

^a EpiGenesis Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTINEOPLASTIC AGENT; CISPLATIN; DNA TOPOISOMERASE INHIBITOR; METHYLTRANSFERASE;

DNA METHYLATION; DRUG RESISTANCE; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR CELL;

EID: 0030941622     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(96)00051-8     Document Type: Review

References (60)

1. Usmani, B.A. (1993) Genomic instability and metastatic progression, Pathobiology 61(2), 109-116.
2. Sweezy, M.A. and Fishel, R. (1994) Multiple pathways leading to genomic instability and tumorigenesis, Ann. NY Acad. Sci. 726, 165-177.
3. Cheng, K.C. and Loeb, L. (1993) Genomic instability and tumor progression: mechanistic considerations, Adv. Cancer Res., 60, 121-156.
4. Hartwell, L. (1992) Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells, Cell, 71(4), 543-546.
5. Honchel, R., Halling, K.C. and Thibodeau, S.N. (1995) Genomic instability in neoplasia, Sem. Cell Biol., 6(1), 45-52.
6. Russo, C.A., Weber, T.K., Volpe, C.M., Stoler, D.L., Petrelli, N.J., Rodriguez-Bigas, M., Burhans, W.C. and Anderson, G.R. (1995) An anoxia inducible endonuclease and enhanced DNA breakage as contributors to genomic instability in cancer, Cancer Res., 55(5), 1122-1128.
7. Nyce, J., Weinhouse, S. and Magee, P.N. (1983) 5-Methylcytosine depletion during tumor development: an extension of the miscoding concept, Br. J. Cancer, 48(4), 463-475.
8. Yamasaki, H., Mesnil, M. and Nakazawa, H. (1992) Interaction and distinction of genotoxic and non-genotoxic events in carcinogenesis, Toxicol. Lett., 64-65, 597-604.
9. Nyce, J., Leonard, S., Canupp, D., Schulz, S. and Wong, S. (1993) Epigenetic mechanisms of drug resistance: drug-induced DNA hypermethylation and drug resistance, Proc. Natl. Acad. Sci. USA, 90(7), 2960-2964.
10. Ribieras, S., Song-Wang, X.G., Martin, V., Lointier, P., Frappart, L. and Dante, R. (1994) Human breast and colon cancers exhibit alterations of DNA methylation patterns at several DNA segments on chromosomes pp. 11 and pp. 17. J. Cell. Biochem., 56(1), 86-96.
11. Rideout, W.M. 3rd, Eversole-Cire, P., Spruck, C.H. 3rd, Hustad, C.M., Coetzee, G.A., Gonzales, F.A. and Jones, P.A. (1994) Progressive increases in the methylation status and heterochromatinization of the myoD CpG island during oncogenic transformation, Mol. Cell. Biol., 14(9), 6143-6152.
12. Herman, J.G., Latif, F., Weng, Y., Lerman, M.I., Zbar, B., Liu, S., Samid, D., Duan, D.S., Gnarra, J.R. and Linehan, W.M. et al. (1994) Silencing of the VHL tumor-suppresser gene by DNA methylation in renal carcinoma, Proc. Natl. Acad. Sci. USA, 91(21), 9700-9704.
13. Lee, Y.W., Klein, C.B., Kargacin, B., Salnikow, K., Kitahara, J., Dowjat, K., Zhitkovich, A., Christie, N.T. and Costa, M. (1995) Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens, Mol. Cell. Biol., 15(5), 2547-2557.
14. Greger, V., Debus, N., Lohmann, D., Hopping, W., Passarge, E. and Horsthemke, B. (1994) Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma, Human Genet., 94(5), 491-496.
15. Costa, M. (1995) Model for the epigenetic mechanism of action of nongenotoxic carcinogens, Am. J. Clin. Nutrition 61(3 Suppl.), 666S-669S.
16. Ferguson, A.T., Lapidus, R.G., Baylin, S.B. and Davidson, N.E. (1995) Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression, Cancer Res., 55(11), 2279-2283.
17. Yoshiura, K., Kanai, Y., Ochiai, A., Shimoyama, Y., Sugimura, T. and Hirohashi, S. (1995) Silencing of the E-cadherin invasion-suppresser gene by CpG methylation in human carcinomas, Proc. Natl. Acad. Sci. USA, 92(16), 7416-7419.
18. Pieretti, M., Powell, D.E., Gallion, H.H., Conway, P.S., Case, E.A. and Turker, M.S. (1995) Hypermethylation at a chromosome 17 'hot spot' is a common event in ovarian cancer, Hum. Pathol., 26(4), 398-401.
19. Moulton, T., Crenshaw, T., Hao, Y., Moosikasuwan, J., Lin, N., Dembitzer, F., Hensle, T., Weiss, L., McMorrow, L. and Loew, T. et al. (1994) Epigenetic lesions at the H19 locus in Wilms' tumor patients, Nature Genet., 7(3), 440-447.
20. Laird, P.W. and Jaenisch, R. (1994) DNA methylation and cancer, Hum. Mol. Genet. 3 Spec. No. 1487-1495.
21. Matsuo, K., Tang, S.H., Zeki, K., Gutman, R.A. and Fagin, J.A. (1993) Aberrant deoxyribonucleic acid methylation in human thyroid tumors, J. Clin. Endocrinol. Metab., 77(4), 991-995.
22. Mills, K.I., Sproul, A.M. and Burnett, A.K. (1993) Methylation of the major breakpoint cluster region (M-bcr) in Philadelphia-positive CML, Leukemia, 17(5), 707-711.
23. Issa, J.P., Vertino, P.M., Wu, J., Sazawal, S., Celano, P., Nelkin, B.D., Hamilton, S.R. and Baylin, S.B. (1993) Increased cytosine DNA-methyltransferase activity during colon cancer progression, J. Natl. Cancer Inst, 85(15), 1235-1240.
24. Ohtani-Fujita, N., Fujita, T., Aoike, A., Osifchin, N.E., Robbins, P.D. and Sakai, T. (1993) CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppresser gene, Oncogene, 8(4), 1063-1067.
25. Baylin, S. (1992), Abnormal regional hypermethylation in cancer cells, AIDS Res. Hum. Retroviruses, 8(5), 811-820.
26. Makos, M., Nelkin, B.D., Chazin, V.R., Cavenee, W.K., Brodeur, G.M. and Baylin, S.B. (1993) DNA hypermethylation is associated with 17p allelic loss in neural tumors, Cancer Res., 53(12), 2715-2718.
27. Sakai, T., Toguchida, J., Ohtani, N., Yandell, D.W., Rapaport, J.M. and Dryja, T.P. (1991) Allele-specific hypermethylation of the retinoblastoma tumor-suppresser gene, Am. J. Human Genet., 48(5), 880-888.
28. Peltomaki, P. (1991) DNA methylation changes in human testicular cancer, Biochim. Biophys. Acta, 1096(3), 187-196
29. Nyce, J., Mylott, D., Leonard, S., Willis, L. and Kataria, A. (1989) Detection of drug-induced DNA hypermethylation in human cells exposed to cancer chemotherapy agents, J. Liq. Chrom., 12(8), 1313-1321.
30. Nyce, J.W. (1989) Drug-induced DNA hypermethylation and drug resistance in human tumors, Cancer Res., 49(21), 5829-5836.
31. Griffin, S., Branch, P., Xu, Y.Z. and Karran, P. (1994) DNA mismatch binding and incision at modified guanine bases by extracts of mammalian cells: implications for tolerance to DNA methylation damage, Biochemistry, 33(16), 4787-4793.
32. Kastan, M.B., Gowans, B.J. and Lieberman, M.W. (1982) Methylation of deoxycytidine incorporated by excision repair synthesis of DNA, Cell, 30(2), 509-516.
33. Nyce, J., Liu, L. and Jones, P.A. (1986) Variable effects of DNA synthesis inhibitors upon DNA methylation in mammalian cells, Nucleic Acids Res., 14(10), 4353-4367.
34. Nyce, J. (1991) Gene silencing in mammalian cells by direct incorporation of electroporated 5-methyl-2′deoxycytidine 5′-triphosphate, Somatic Cell Mol. Genet., 17, 543-550.
35. Leonard, S.A., Wong, S.C. and Nyce, J.W. (1993) Quantitation of 5-methylcytosine by one-dimensional high-performance thin-layer chromatography, J. Chrom., 645, 189-192.
36. Reid, T.R., Merigan, T.C. and Basham, T.Y. (1992) Resistance to Interferon α in a mouse B-cell lymphoma involves DNA methylation, J. Interferon Res., 12(2), 131-137.
37. Wilson, V. and Jones, P. (1983) Inhibition of DNA methylation by chemical carcinogens in vitro, Cell, 32, 239-246.
38. Lepre, C.A. and Lippard, S.J. (1990) Interaction of platinum antitumor compounds with DNA, in: F. Eckstein and D.M. Lilley (Eds.), Nucleic Acids and Molecular Biology, Vol. 4, pp. 3-9, Springer-Verlag, Berlin.
39. Visse, R. and deRuijter, M., Brouwer, J.A. and van de Putte, P. (1991) Uvr excision repair protein complex of Escherichia coli binds to the convex side of a cisplatin-induced kink in the DNA, J. Biol. Chem., 266, 7609-7617.
40. Schwartz, A. and Leng, M. (1994) Dnase I footprinting of cis- and trans-diamminedichloroplatinum(II)-modified DNA, J. Mol. Biol., 236, 969-974.
41. Bellon, S.F., Coleman, J.H. and Lippard, S.J. (1991) DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum (II), Biochemistry, 30(32), 8026-8035.
42. Suck, D., Lahm, A. and Oefner, C. (1988) Structure refined to 2 Angstrom of a nicked DNA octanucleotide complex with DNase I, Nature, 332, 464-468.
43. Hare, J.T. and Taylor, J.H. (1985) One role for DNA methylation in vertebrate cells is strand discrimination in mismatch repair, Proc. Natl. Acad. Sci. USA, 82(21), 7350-7354.
44. Razin, A. and Cedar, H. (1991) DNA methylation and gene expression, Microbiol. Rev., 55(3), 451-458.
45. Bednarik, D.P., Duckett, C., Kim, S.U., Perez, V.L., Griffis, K., Guenthner, P.C. and Folks, T.M. (1991) DNA CpG methylation inhibits binding of NF-kappa B proteins to the HIV-1 long terminal repeat cognate DNA motifs, New Biologist, 3(10), 969-976.
46. Gutekunst, K.A., Kashanchi, F., Brady, J.N. and Bednarik, D.P. (1993) Transcription of the HIV-1 LTR is regulated by the density of DNA CpG methylation. J. Acq. Immune Defic. Syndromes, 6(6), 541-549.
47. 6-methylguanine DNA methyltransferase by 5-methylcytosine, Cancer Res., 54(2), 327-329.
48. Schonfeld, S., Schulz, S. and Nyce, J.W. (1992) Effects of inhibitors of topoisomerases I and II on DNA methylation and DNA synthesis in human colonie adenocarcinoma cells in vitro, Intern. J. Oncology, 1, 807-814.
49. Nakaya, K., Chou, S., Kaneko, M., and Nakamura, Y. (1991) Topoisomerase inhibitors have potent differentiation-inducing activity for human and mouse myeloid leukemia cells. Jpn. J. Cancer Res., 82, 184-191.
50. Rappa, G., Lorico, A. and Sartorelli, A.C. (1990) Induction of the differentiation of WEHI-3B D + monomyelocytic leukemia cells by inhibitors of topoisomerase II, Cancer Res., 50, 6723-6730.
51. Holden, J.A., Rolfson, D.H. and Wittwer (1990) Human DNA topoisomerase II: evaluation of enzyme activity in normal and neoplastic tissues, Biochemistry, 29(8), 2127-2134.
52. Hsiang, Y.H., Wu, H.Y. and Liu, L.F. (1988) Proliferation-dependent regulation of DNA topoisomerase II in cultured cells, Cancer Res., 48, 3230-3235.
53. Shapiro, R. and Klein, R.S. (1966) The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications, Biochemistry, 5(7), 2358-2362.
54. Coulondre, C., Miller, J.H., Farabaugh, P.J. and Gilbert, W. (1978) Molecular basis of base substitution hotspots in Escherichia coli, Nature, 274(5673), 775-780.
55. Duncan, B.K. and Miller, J.H. (1980) Mutagenic deamination of cytosine residues in DNA, Nature, 287(5782), 560-561.
56. Wang, R.Y., Kuo, K.C., Gehrke, C.W., Huanh, L.H. and Ehrlich, M. (1982) Heat and alkali-induced deamination of 5-methylcytosine and cytosine residues in DNA, Biochim. Biophys. Acta, 697(3), 371-377.
57. Rideout, W.M. 3d, Coetzee, G.A., Olumi, A.F. and Jones, P.A. (1990) 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes, Science, 249(4974), 1288-1290.
58. Perry, M.E., Rolfe, M., McIntyre, P., Commane, M. and Stark, G.R. (1992) Induction of gene amplification by 5-aza2'-deoxycytidine, Mutation Res., 276(3), 189-197.
59. Roninson, I.B. (1992) From amplification to function: the case of the MDR1 gene, Mutation Res., 276(3), 151-161.
60. Harnevo. L.E. and Agur, Z. (1992) Drug resistance as a dynamic process in a model for multistep gene amplification under various levels of selection stringency, Cancer Chemother. Pharmacol., 30(6), 469-476.